Congress Asset Management CO Supernus Pharmaceuticals, Inc. Transaction History
Congress Asset Management CO
- $13.6 Billion
- Q1 2024
A detailed history of Congress Asset Management CO transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Congress Asset Management CO holds 1,032,141 shares of SUPN stock, worth $27.1 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
1,032,141
Previous 920,808
12.09%
Holding current value
$27.1 Million
Previous $26.6 Million
32.11%
% of portfolio
0.26%
Previous 0.22%
Shares
12 transactions
Others Institutions Holding SUPN
# of Institutions
260Shares Held
57.3MCall Options Held
84.1KPut Options Held
61.2K-
Black Rock Inc. New York, NY10.4MShares$272 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.21MShares$163 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY3.57MShares$93.7 Million1.66% of portfolio
-
Macquarie Group LTD Australia, C32.67MShares$70 Million0.1% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.56MShares$67.1 Million0.02% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.4B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...